Form 8-K - Current report:
SEC Accession No. 0001125345-23-000063
Filing Date
2023-03-24
Accepted
2023-03-24 16:33:21
Documents
14
Period of Report
2023-03-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20230322.htm   iXBRL 8-K 28149
2 EX-99.1 exhibit99-1_zynyzfdaapprov.htm EX-99.1 10089
6 MACROGENICS LOGO image_0.jpg GRAPHIC 16939
  Complete submission text file 0001125345-23-000063.txt   192550

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20230322.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20230322_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20230322_pre.xml EX-101.PRE 12706
8 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20230322_htm.xml XML 4108
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 23760320
SIC: 2834 Pharmaceutical Preparations